指导类风湿关节炎免疫抑制治疗的缓解定义:哪个最适合其目的?
该研究基于8项随机对照试验的个体患者数据(n=4423),比较6种缓解定义对第二年影像学良好结局和功能良好结局的预测准确性。结果显示3VBoolean定义对影像学良好结局和功能良好结局的预测最准确,支持将3VBoolean缓解用于指导免疫抑制治疗,并建议联合以患者为中心的目标采用双目标策略。
要点
- 3VBoolean对影像学良好结局的预测准确性为51.1%,高于Boolean的38.8%和Updated-Boolean的44.1%。
- 3VBoolean对功能良好结局的正确预测比例最高(50.3%),Boolean最低(43.8%)。
- 达到缓解者中影像学良好结局比例从82.4%(3VBoolean)到83.9%(SDAI)不等。
核心结论
- 3VBoolean定义对影像学良好结局和功能良好结局的预测最准确,避免了相当比例患者过度治疗的风险且不增加影像学损伤进展,支持3VBoolean缓解更适合指导免疫抑制治疗。
- 患者视角必须保持核心地位,最好通过额外的以患者为中心的目标来满足,即双目标策略。
研究设计与样本
- 基于随机对照试验个体患者数据的Meta分析。
- 纳入8项随机对照试验,共4423例患者。
主要发现
- Boolean、SDAI、CDAI、Updated-Boolean、Boolean-PhGA和3VBoolean的达标率分别为24%、27%、28%、32%、33%和43%。
- 达到缓解者中影像学良好结局比例从82.4%(3VBoolean)到83.9%(SDAI)。
- 3VBoolean对影像学良好结局的预测准确性为51.1%,Boolean为38.8%,Updated-Boolean为44.1%。
- 功能良好结局的相对风险从1.16(Boolean)到1.05(3VBoolean)。
- 功能良好结局正确预测比例最高为3VBoolean(50.3%),最低为Boolean(43.8%)。
关键数值与推荐
- Boolean定义:患者总体评估(PGA)≤1。
- SDAI定义:SDAI≤3.3。
- CDAI定义:CDAI≤2.8。
- Updated-Boolean定义:PGA≤2。
- Boolean-PhGA定义:以医生总体评估(PhGA≤1)替代PGA。
临床怎么用
- 作者认为3VBoolean缓解更适合指导免疫抑制治疗。
- 作者建议采用双目标策略,在3VBoolean缓解之外增加以患者为中心的目标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess which definition of remission best predicts good radiographic outcome (GRO) and good functional outcome (GFO) in rheumatoid arthritis, focusing the updated American College of Rheumatology/European Alliance of Associations for Rheumatology criteria. MATERIAL AND METHODS: Meta-analyses of individual patient data (IPD) from randomised controlled trials (RCTs). Six definitions of remission were considered: (1) Boolean with Patient Global Assessment (PGA)≤1 (Boolean); (2) Simplified Disease Activity Index (SDAI)≤3.3; (3) Clinical Disease Activity Index (CDAI)≤2.8; (4) Boolean with PGA≤2 (Updated-Boolean); (5) Boolean with Physician Global Assessment (PhGA≤1) replacing PGA (Boolean-PhGA) and (6) Boolean excluding PGA (3VBoolean). GRO was defined as a worsening ≤0.5 units in radiographic score and GFO as a no worsening in Health Assessment Questionnaire (HAQ), that is, ∆HAQ-DI≤0.0 units. Relationships between each remission definition at 6 and/or 12 months and GRO and GFO during the second year were analysed. Pooled probabilities for each outcome for each definition and their predictive accuracy were estimated. RESULTS: IPD from eight RCTs (n=4423) were analysed. Boolean, SDAI, CDAI, Updated-Boolean, Boolean-PhGA and 3VBoolean were achieved by 24%, 27%, 28%, 32%, 33% and 43% of all patients, respectively. GRO among patients achieving remission ranged from 82.4% (3VBoolean) to 83.9% (SDAI). 3VBoolean showed the highest predictive accuracy for GRO: 51.1% versus 38.8% (Boolean) and 44.1% (Updated-Boolean). The relative risk of GFO ranged from 1.16 (Boolean) to 1.05 (3VBoolean). However, the proportion of GFO correctly predicted was highest for the 3VBoolean (50.3%) and lowest for the Boolean (43.8%). CONCLUSION: 3VBoolean definition provided the most accurate prediction of GRO and GFO, avoiding the risk of overtreatment in a substantial proportion of patients without increment in radiographic damage progression, supporting the proposal that 3VBoolean remission is preferable to guide immunosuppressive treatment. The patient's perspective, which must remain central, is best served by an additional patient-oriented target: a dual-target approach.
引用
- Duarte C, Ferreira RJO, Welsing PMJ, et al. Remission definitions guiding immunosuppressive therapy in rheumatoid arthritis: which is best fitted for the purpose? RMD Open. 2024. PMID: 38443090. doi:10.1136/rmdopen-2023-003972
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。